Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
2.100
-0.170 (-7.49%)
At close: Dec 27, 2024, 4:00 PM
2.130
+0.030 (1.43%)
After-hours: Dec 27, 2024, 6:52 PM EST
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $141.17 million as of December 27, 2024. Its market cap has increased by 103.98% in one year.
Market Cap
141.17M
Enterprise Value
-76.70M
1-Year Change
103.98%
Ranking
Category
Stock Price
2.10
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $141.17M, a decrease of -64.99%. That is a compound annual growth rate of -26.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2024 | 152.60M | 104.98% |
| Dec 29, 2023 | 74.45M | -23.65% |
| Dec 30, 2022 | 97.50M | -64.90% |
| Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 142.85M |
| Metagenomi | 141.09M |
| XBiotech | 139.00M |
| Vaxart | 138.49M |
| Tenaya Therapeutics | 131.51M |
| PepGen | 131.36M |
| Protalix BioTherapeutics | 131.07M |
| Achieve Life Sciences | 130.34M |